Reciprocal regulation controlling the expression of CPI-17, a specific inhibitor protein for the myosin light chain phosphatase in vascular smooth muscle cells

American Journal of Physiology - Cell Physiology

Volumn 303, Issue 1, 2012, Pages

  Kim, Jee In ^a   Urban, Mark ^a   Young, Garbo D ^a   Eto, Masumi ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Excitation transcription coupling; Inflammation; Protein phosphatase 1; Smooth muscle contraction and differentiation

Indexed keywords

INHIBITOR PROTEIN; INTERLEUKIN 1BETA; KRUPPEL LIKE FACTOR 4; MYOCARDIN; MYOSIN LIGHT CHAIN PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN CPI 17; RHO KINASE; SEROTONIN; SORBITOL; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DNA FLANKING REGION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER;

ANIMALS; AORTA; CELLS, CULTURED; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MUSCLE CONTRACTION; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOSIN-LIGHT-CHAIN PHOSPHATASE; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PLATELET-DERIVED GROWTH FACTOR; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEROTONIN; SIGNAL TRANSDUCTION; SORBITOL; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84863518033     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00118.2012     Document Type: Article

References (67)

1. Boberg L, Poljakovic M, Rahman A, Eccles R, Arner A. Role of Rho-kinase and protein kinase C during contraction of hypertrophic detrusor in mice with partial urinary bladder outlet obstruction. BJU Int 109: 132-140, 2012.
2. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M, Hein L, Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 119: 2634-2647, 2009.
3. 2+channels. Circ Res 86: 760-767, 2000.
4. Chang S, Hypolite JA, DiSanto ME, Changolkar A, Wein AJ, Chacko S. Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rhokinase-β and CPI-17. Am J Physiol Renal Physiol 290: F650-F656, 2006.
5. Chang S, Hypolite JA, Mohanan S, Zderic SA, Wein AJ, Chacko S. Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder. Lab Invest 89: 823-832, 2009.
6. Conrad PW, Rust RT, Han J, Millhorn DE, Beitner-Johnson D. Selective activation of p38α and p38γ by hypoxia role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem 274: 23570-23576, 1999.
7. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee T, Miano JM, Ivey KN, Srivastava D. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710, 2009.
8. Courey AJ, Tjian R. Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 55: 887-898, 1988.
9. Dakshinamurti S, Mellow L, Stephens NL. Regulation of pulmonary arterial myosin phosphatase activity in neonatal circulatory transition and in hypoxic pulmonary hypertension: a role for CPI-17. Pediatr Pulmonol 40: 398-407, 2005.
10. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284: 3728-3738, 2009.
11. Deaton RA, Gan Q, Owens GK. Spl-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle. Am J Physiol Heart Circ Physiol 296: H1027-H1037, 2009.
12. 2+sensitization of contraction in arterial smooth muscle. Circ Res 100: 121-129, 2007.
13. Eguchi S, Hirata Y, Imai T, Kanno K, Marumo F. Phenotypic change of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 134: 222-228, 1994.
14. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MVG, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli G. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease. Cell Death Differ 16: 1590-1598, 2009.
15. Eto M. Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors. J Biol Chem 284: 35273-35277, 2009.
16. Georgijevic S, Subramanian Y, Rollins EL, Starovic-Subota O, Tang AC, Childs SJ. Spatiotemporal expression of smooth muscle markers in developing zebrafish gut. Dev Dyn 236: 1623-1632, 2007.
17. Gomez-Pinilla PJ, Gomez MF, Hedlund P, Swärd K, Hellstrand P, Camello PJ, Pozo MJ, Andersson K. Effect of melatonin on age associated changes in guinea pig bladder function. J Urol 177: 1558-1561, 2007.
18. Grassie ME, Moffat LD, Walsh MP, MacDonald JA. The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1delta. Arch Biochem Biophys 510: 147-159, 2011.
19. Hartshorne DJ, Ito M, Erdodi F. Role of protein phosphatase type 1 in contractile functions: myosin phosphatase. J Biol Chem 279: 37211-37214, 2004.
20. Hu W, Mahavadi S, Li F, Murthy KS. Upregulation of RGS4 and downregulation of CPI-17 mediate inhibition of colonic muscle contraction by interleukin-1β. Am J Physiol Cell Physiol 293: C1991-C2000, 2007.
21. Ihara E, Chappellaz M, Turner SR, McDonald JA. The contribution of protein kinase C and CPI-17 signaling pathways to hypercontractility in murine experimental colitis. Neurogastroenterol Motil 24: e15-e26, 2012.
22. Jin H, Sperka T, Herrlich P, Morrison H. Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase. Nature 442: 576-579, 2006.
23. Juan Y, Li S, Levin RM, Kogan BA, Schuler C, Leggett RE, Huang C, Mannikarottu A. The effect of ischemia/reperfusion on rabbit bladderrole of Rho-kinase and smooth muscle regulatory proteins. Urology 73: 1126-1130, 2009.
24. Khatri JJ, Joyce KM, Brozovich FV, Fisher SA. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation. J Biol Chem 276: 37250-37257, 2001.
25. 2+ sensitization force of smooth muscle contraction. J Biol Chem 284: 21569-21579, 2009.
26. 2+sensitization after subarachnoid hemorrhage. J Cereb Blood Flow Metab 32: 341-352, 2011.
27. Kim JI, Young GD, Jin L, Somlyo AV, Eto M. Expression of CPI-17 in smooth muscle during embryonic development and in neointimal lesion formation. Histochem Cell Biol 132: 191-198, 2009.
28. Kitazawa T, Masuo M, Somlyo AP. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 88: 9307-910, 1991.
29. Kitazawa T, Semba S, Huh YH, Kitazawa K, Eto M. Nitric oxideinduced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1. J Physiol 587: 3587-603, 2009.
30. Layne MD, Yet S, Maemura K, Hsieh C, Liu X, Ith B, Lee M, Perrella MA. Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ Res 90: 728-736, 2002.
31. 2+desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 272: 5063-5068, 1997.
32. Liu N, Olson EN. MicroRNA regulatory networks in cardiovascular development. Dev Cell 18: 510-525, 2010.
33. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280: 9719-9727, 2005.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-delta delta C(T)] method. Methods 25: 402-408, 2001.
35. McDonald OG, Owens GK. Programming smooth muscle plasticity with chromatin dynamics. Circ Res 100: 1428-1441, 2007.
36. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-C97, 2007.
37. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35: 577-593, 2003.
38. Morin C, Fortin S, Cantin AM, Rousseau E. Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. Am J Respir Cell Mol Biol 45: 366-375, 2011.
39. Ohama T, Hori M, Fujisawa M, Kiyosue M, Hashimoto M, Ikenoue Y, Jinno Y, Miwa H, Matsumoto T, Murata T, Ozaki H. Downregulation of CPI-17 contributes to dysfunctional motility in chronic intestinal inflammation model mice and ulcerative colitis patients. J Gastroenterol 43: 858-865, 2008.
40. Ohama T, Hori M, Sato K, Ozaki H, Karaki H. Chronic treatment with interleukin-1beta attenuates contractions by decreasing the activities of CPI-17 and MYPT-1 in intestinal smooth muscle. J Biol Chem 278: 48794-48804, 2003.
41. Ono H, Ichiki T, Fukuyama K, Iino N, Masuda S, Egashira K, Takeshita A. cAMP-response element-binding protein mediates tumor necrosis factor-α-induced vascular smooth muscle cell migration. Arterioscler Thromb Vasc Biol 24: 1634-1639, 2004.
42. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004.
43. Ozaki H, Yasuda K, Kim Y, Egawa M, Kanzaki H, Nakazawa H, Hori M, Seto M, Karaki H. Possible role of the protein kinase C/CPI-17 pathway in the augmented contraction of human myometrium after gestation. Br J Pharmacol 140: 1303-1312, 2003.
44. Pagiatakis C, Gordon JW, Ehyai S, McDermott JC. A novel RhoA/ ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression. J Biol Chem 287: 8361-8370, 2012.
45. Parmacek MS. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. Circ Res 100: 633-644, 2007.
46. Qiu P, Li L. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ Res 90: 858-865, 2002.
47. Sakai H, Chiba Y, Hirano T, Misawa M. Possible involvement of CPI-17 in augmented bronchial smooth muscle contraction in antigeninduced airway hyper-responsive rats. Mol Pharmacol 68: 145-151, 2005.
48. Seay U, Sedding D, Krick S, Hecker M, Seeger W, Eickelberg O. Transforming growth factor-beta-dependent growth inhibition in primary vascular smooth muscle cells is p38-dependent. J Pharmacol Exp Ther 315: 1005-1012, 2005.
49. Sellak H, Yang X, Cao X, Cornwell T, Soff GA, Lincoln T. Sp1 transcription factor as a molecular target for nitric oxide-and cyclic nucleotide-mediated suppression of cGMP-dependent protein kinase-Iα expression in vascular smooth muscle cells. Circ Res 90: 405-412, 2002.
50. Senba S, Eto M, Yazawa M. Identification of trimeric myosin phosphatase (PP1M) as a target for a novel PKC-potentiated protein phosphatase-1 inhibitory protein (CPI17) in porcine aorta smooth muscle. J Biochem 125: 354-362, 1999.
51. Song J, Eyster KM, Kost CK, Kjellsen B, Martin DS. Involvement of protein kinase C-CPI-17 in androgen modulation of angiotensin II-renal vasoconstriction. Cardiovasc Res 85: 614-621, 2010.
52. Tan NY, Khachigian LM. Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29: 2483-2488, 2009.
53. Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E. Functional inactivation of NF2/merlin in human mesothelioma. Lung Cancer 64: 140-147, 2009.
54. Trinkle-Mulcahy L, Ichikawa K, Hartshorne DJ, Siegman MJ, Butler T. Thiophosphorylation of the 130-kDa subunit is associated with a decreased activity of myosin light chain phosphatase in a-toxin-permeabilized smooth muscle. J Biol Chem 270: 18191-18194, 1995.
55. Ullmer C, Schmuck K, Kalkman HO, Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 370: 215-221, 1995.
56. Wada H, Hasegawa K, Morimoto T, Kakita T, Yanazume T, Abe M, Sasayama S. Calcineurin-GATA-6 pathway is involved in smooth muscle-specific transcription. J Cell Biol 156: 983-991, 2002.
57. 2+ channels modulate expression of smooth muscle differentiation marker genes via a Rho kinase/myocardin/SRF-dependent mechanism. Circ Res 95: 406-414, 2004.
58. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res 98: 868-878, 2006.
59. Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK. A G/C element mediates repression of the SM22α promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res 95: 981-988, 2004.
60. Wang Z, Wang D, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428: 185-189, 2004.
61. 2+sensitivity of protein kinase C-induced contraction in rabbit smooth muscle. J Physiol 535: 553-564, 2001.
62. Woodsome TP, Polzin A, Kitazawa K, Eto M, Kitazawa T. Agonistand depolarization-induced signals for myosin light chain phosphorylation and force generation of cultured vascular smooth muscle cells. J Cell Sci 119: 1769-1780, 2006.
63. Wu X, Somlyo AV, Somlyo AP. Cyclic-GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphatase. Biochem Biophys Res Commun 220: 658-663, 1996.
64. Yet S, Folta SC, Jain MK, Hsieh C, Maemura K, Layne MD, Zhang D, Marria PB, Yoshizumi M, Chin MT, Perrella MA, Lee M. Molecular cloning, characterization, and promoter analysis of the mouse Crp2/ SmLim gene: Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice. J Biol Chem 273: 10530-10537, 1998.
65. Yin F, Herring BP. GATA-6 can act as a positive or negative regulator of smooth muscle-specific gene expression. J Biol Chem 280: 4745-4752, 2005.
66. Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 7: 85, 2006.
67. Zeng Y, Zhuang S, Gloddek J, Tseng C, Boss GR, Pilz RB. Regulation of cGMP-dependent protein kinase expression by Rho and Krüppel-like transcription factor-4. J Biol Chem 281: 16951-16961, 2006.